Marco Investment Management LLC Bristol Myers Squibb CO Transaction History

Marco Investment Management LLC

  • $1.15 Billion
  • Q3 2024

A detailed history of Marco Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Marco Investment Management LLC holds 33,638 shares of BMY stock, worth $1.99 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
33,638
Previous 36,888 8.81%
Holding current value
$1.99 Million
Previous $1.53 Million 13.65%
% of portfolio
0.15%
Previous 0.14%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$39.66 - $51.75 $128,894 - $168,187
-3,250 Reduced 8.81%
33,638 $1.74 Million
Q2 2024

Aug 07, 2024
BUY
$40.25 - $52.99 $2,012 - $2,649
50 Added 0.14%
36,888 $1.53 Million
Q1 2024

May 08, 2024
BUY
$47.98 - $54.4 $66,260 - $75,126
1,381 Added 3.89%
36,838 $2 Million
Q4 2023

Feb 05, 2024
SELL
$48.48 - $57.85 $192,271 - $229,433
-3,966 Reduced 10.06%
35,457 $1.82 Million
Q3 2023

Nov 07, 2023
SELL
$57.89 - $64.73 $380,221 - $425,146
-6,568 Reduced 14.28%
39,423 $2.29 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $58,485 - $64,939
-918 Reduced 1.96%
45,991 $2.94 Million
Q1 2023

May 11, 2023
BUY
$65.71 - $74.53 $35,023 - $39,724
533 Added 1.15%
46,909 $3.25 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $132,988 - $157,476
-1,942 Reduced 4.02%
46,376 $3.34 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $3 - $1,844
-24 Reduced 0.05%
48,318 $3.44 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $3 - $1,844
-24 Reduced 0.05%
48,318 $3.44 Million
Q2 2022

Aug 05, 2022
BUY
$72.62 - $79.98 $87,507 - $96,375
1,205 Added 2.56%
48,342 $3.72 Million
Q1 2022

May 11, 2022
BUY
$61.48 - $73.72 $6,148 - $7,372
100 Added 0.21%
47,137 $3.44 Million
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $73,473 - $85,652
-1,370 Reduced 2.83%
47,037 $2.93 Million
Q3 2021

Nov 10, 2021
BUY
$59.17 - $69.31 $95,263 - $111,589
1,610 Added 3.44%
48,407 $2.86 Million
Q2 2021

Aug 11, 2021
BUY
$61.91 - $67.42 $283,547 - $308,783
4,580 Added 10.85%
46,797 $3.13 Million
Q1 2021

May 06, 2021
BUY
$59.34 - $66.74 $35,485 - $39,910
598 Added 1.44%
42,217 $2.67 Million
Q4 2020

Feb 11, 2021
BUY
$57.74 - $65.43 $106,934 - $121,176
1,852 Added 4.66%
41,619 $2.58 Million
Q3 2020

Oct 27, 2020
BUY
$57.43 - $63.64 $424,982 - $470,936
7,400 Added 22.86%
39,767 $2.4 Million
Q2 2020

Jul 21, 2020
BUY
$54.82 - $64.09 $214,565 - $250,848
3,914 Added 13.76%
32,367 $1.9 Million
Q1 2020

Apr 17, 2020
SELL
$46.4 - $67.43 $29,232 - $42,480
-630 Reduced 2.17%
28,453 $1.59 Million
Q4 2019

Feb 11, 2020
BUY
$49.21 - $64.19 $11,170 - $14,571
227 Added 0.79%
29,083 $1.87 Million
Q3 2019

Nov 12, 2019
SELL
$42.77 - $50.71 $43,625 - $51,724
-1,020 Reduced 3.41%
28,856 $1.46 Million
Q2 2019

Aug 06, 2019
BUY
$44.62 - $49.34 $249,336 - $275,711
5,588 Added 23.01%
29,876 $1.36 Million
Q1 2019

May 02, 2019
SELL
$45.12 - $53.8 $235,887 - $281,266
-5,228 Reduced 17.71%
24,288 $1.16 Million
Q4 2018

Feb 14, 2019
SELL
$48.76 - $63.23 $29,646 - $38,443
-608 Reduced 2.02%
29,516 $1.53 Million
Q3 2018

Nov 09, 2018
SELL
$55.19 - $62.25 $292,286 - $329,676
-5,296 Reduced 14.95%
30,124 $1.87 Million
Q2 2018

Aug 10, 2018
BUY
$50.53 - $62.98 $307,980 - $383,863
6,095 Added 20.78%
35,420 $1.96 Million
Q1 2018

May 01, 2018
SELL
$59.92 - $68.98 $17,976 - $20,694
-300 Reduced 1.01%
29,325 $1.86 Million
Q4 2017

Feb 15, 2018
BUY
$59.94 - $65.35 $89,910 - $98,024
1,500 Added 5.33%
29,625 $1.82 Million
Q3 2017

Nov 14, 2017
SELL
$55.23 - $63.74 $211,917 - $244,570
-3,837 Reduced 12.0%
28,125 $1.79 Million
Q2 2017

Aug 11, 2017
BUY
N/A
31,962
31,962 $1.78 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Marco Investment Management LLC Portfolio

Follow Marco Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marco Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email